Results 101 to 110 of about 2,807,261 (278)

A case of atypical scleroderma renal crisis

open access: yesEuropean Journal of Case Reports in Internal Medicine
We present the case of a 63-year-old female diagnosed with atypical SSc in the setting of acute SRC. She was undergoing work-up for progressive dyspnoea in the outpatient setting when she was found to have newly diagnosed restrictive lung pathology and ...
Ayushi Lalwani   +6 more
doaj   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Using a RESTful messaging and registry system to support a range a distributed applications

open access: yesRevista Colombiana de Computación, 2010
Tycho was conceived in 2003 in response to a need by the GridRM [1], a resourcemonitoring project for a “light-weight”, scalable and easy to use wide-area distributed registry and messaging system.
Mark Baker   +5 more
doaj  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

A Machine Learning Framework to Evaluate Vegetation Modeling in Earth System Models

open access: yesJournal of Advances in Modeling Earth Systems
Vegetation gross primary productivity (GPP) is the single largest carbon flux of the terrestrial biosphere which, in turn, is responsible for sequestering 25%–30% of anthropogenic carbon dioxide emissions.
Ranjini Swaminathan   +2 more
doaj   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

In Memoriam: Professor Emeritus Philip Adams

open access: yesAustralasian Orthodontic Journal, 1998
Reading John
doaj   +1 more source

The utility of impact data in flood forecast verification for anticipatory actions: Case studies from Uganda and Kenya

open access: yesJournal of Flood Risk Management
Skilful flood forecasts have the potential to inform preparedness actions across scales, from smallholder farmers through to humanitarian actors, but require verification first to ensure such early warning information is robust.
Faith Mitheu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy